WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. World Health Organization; [cited 2023 Jun 12]. Available from: https://covid19.who.int/.
Bonanad C, García-Blas S, Tarazona-Santabalbina F, Sanchis J, Bertomeu-González V, Fácila L, et al. The effect of age on mortality in patients with COVID-19: A meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915–8.
Article PubMed PubMed Central Google Scholar
Aveyard P, Gao M, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021;9(8):909–23.
Article PubMed PubMed Central CAS Google Scholar
Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS ONE. 2020;15:e0238215.
Article PubMed PubMed Central CAS Google Scholar
Gao Y, Chen Y, Liu M, Shi S, Tian J. Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis. J Infect. 2020;81(2):e93–5.
Article PubMed PubMed Central CAS Google Scholar
Fernández-de-Las-Peñas C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: A systematic review of the literature. Viruses. 2022;14(12):2629.
Article PubMed PubMed Central Google Scholar
Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102–7.
Article PubMed CAS Google Scholar
Dangayach NS, Newcombe V, Sonnenville R. Acute neurologic complications of COVID-19 and postacute sequelae of COVID-19. Crit Care Clin. 2022;38(3):553–70.
Article PubMed PubMed Central Google Scholar
Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):141.
Article PubMed PubMed Central CAS Google Scholar
Willett BJ, Grove J, MacLean OA, Wilkie C, De Lorenzo G, Furnon W, et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022;7(8):1161–79.
Article PubMed PubMed Central CAS Google Scholar
McCallum M, Czudnochowski N, Rosen LE, Zepeda SK, Bowen JE, Walls AC, et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science. 2022;375(6583):864–8.
Article PubMed PubMed Central CAS Google Scholar
Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in south Africa during the COVID-19 Omicron wave compared with previous waves. JAMA. 2022;327(6):583.
Article PubMed CAS Google Scholar
Stepanova M, Lam B, Younossi E, Felix S, Ziayee M, Price J, et al. The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19. BMC Infect Dis. 2022;22(1):702.
Article PubMed PubMed Central CAS Google Scholar
Willan J, Agarwal G, Bienz N. Mortality and burden of post-COVID-19 syndrome have reduced with time across SARS-CoV-2 variants in haematology patients. Br J Haematol. 2023;201(4):640–4.
Article PubMed CAS Google Scholar
Cortellini A, Tabernero J, Mukherjee U, Salazar R, Sureda A, Maluquer C, et al. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry. Lancet Oncol. 2023;24(4):335–46.
Article PubMed PubMed Central Google Scholar
Reiner RC, Collins JK, Team C1F, Murray CJ. Forecasting the trajectory of the COVID-19 pandemic under plausible variant and intervention scenarios: A global modelling study [Internet]. SSRN Journal [cited 2023 Jul 13]. Available from: https://ssrn.com/abstract=4126660.
Amanatidou E, Gkiouliava A, Pella E, Serafidi M, Tsilingiris D, Vallianou NG, et al. Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges. Metabolism Open. 2022;14:100180.
Article PubMed PubMed Central CAS Google Scholar
Zisis SN, Durieux JC, Mouchati C, Perez JA, McComsey GA. The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: A multicenter study from a large national health research network. Open Forum. Infect Dis. 2022;9(7):ofac228.
Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386(15):1397–408.
Article PubMed CAS Google Scholar
Najjar-Debbiny R, Gronich N, Weber G, Khoury J, Amar M, Stein N, et al. Effectiveness of Paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients. Clin Infect Dis. 2023;76(3):e342–9.
Article PubMed CAS Google Scholar
Xie Y, Choi T, Al-Aly Z. Association of treatment with nirmatrelvir and the risk of post–COVID-19 condition. JAMA Intern Med. 2023;183(6):554–64.
Article PubMed PubMed Central CAS Google Scholar
Peluso MJ, Anglin K, Durstenfeld MS, Martin JN, Kelly JD, Hsue PY, et al. Effect of oral Nirmatrelvir on long COVID symptoms: 4 cases and rationale for systematic studies. Pathog Immun. 2022;7(1):95–103.
PubMed PubMed Central Google Scholar
Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic [Internet]. World Health Organization; [cited 2023 Jun 28]. Available from: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic
Chou SH, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021;4(5):e2112131.
Article PubMed PubMed Central Google Scholar
Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267–9.
Article PubMed CAS Google Scholar
Solomon T. Neurological infection with SARS-CoV-2 - the story so far. Nat Rev Neurol. 2021;17(2):65–6.
Article PubMed PubMed Central CAS Google Scholar
Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T, et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology. 2021;97(23):e2269–81.
Article PubMed PubMed Central CAS Google Scholar
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of Coronavirus disease 2019: A review. JAMA Neurol. 2020;77(8):1018.
Article PubMed PubMed Central Google Scholar
Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697–707.
Article PubMed PubMed Central CAS Google Scholar
Kamasak B, Ulcay T, Nisari M, Gorgulu O, Akca V, Alpaslan M, et al. Effects of COVID-19 on brain and cerebellum: a voxel based morphometrical analysis. Bratisl Lek Listy. 2023;124(6):442–8.
Paolini M, Palladini M, Mazza MG, Colombo F, Vai B, Rovere-Querini P, et al. Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study. Eur Neuropsychopharmacol. 2023;68:1–10.
Article PubMed CAS Google Scholar
Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48(9):2823–33.
Article PubMed PubMed Central CAS Google Scholar
Goehringer F, Bruyere A, Doyen M, Bevilacqua S, Charmillon A, Heyer S, et al. Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur J Nucl Med Mol Imaging. 2023;50(4):1084–9.
Venkataramani V, Winkler F. Cognitive deficits in long COVID-19. N Engl J Med. 2022;387(19):1813–5.
Article PubMed CAS Google Scholar
Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C, et al. Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses. 2019;11(3):200.
Article PubMed PubMed Central CAS Google Scholar
Pourcher V, Gourmelen J, Bureau I, Bouee S. Comorbidities in people living with HIV: an epidemiologic and economic analysis using a claims database in France. PLoS One. 2020;15(12):e0243529.
Comments (0)